1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. Sodium Channel
  4. Nav1.7 Isoform

Nav1.7

 

Nav1.7 Related Products (21):

Cat. No. Product Name Effect Purity
  • HY-N6691
    Veratridine
    Inhibitor 99.96%
    Veratridine (3-Veratroylveracevine) is a plant neurotoxin, a voltage-gated sodium channels (VGSCs) blocker.
  • HY-16723
    Funapide
    Inhibitor 99.72%
    Funapide (TV 45070; XEN402) is a potent Sodium Channel Nav1.7 inhibitor.
  • HY-131182
    DS-1971a
    Inhibitor 99.66%
    DS-1971a is a potent, selective, and orally active NaV1.7 inhibitor, with IC50s of 22.8 and 59.4 nM for hNaV1.7 and mNaV1.7, respectively.
  • HY-112279
    GNE-131
    Inhibitor 98.97%
    GNE-131 is a potent and selective inhibitor of human sodium channel NaV1.7, with an IC50 of 3 nM.
  • HY-131870
    GX-201
    Inhibitor 99.14%
    GX-201 is a selective NaV1.7 inhibitor, with an IC50 of <3.2 nM for hNaV1.7.
  • HY-16723A
    (R)-Funapide
    Inhibitor 98.05%
    (R)-Funapide ((R)-TV 45070) is the less active R-enantiomer of Funapide.
  • HY-139081
    GDC-0310
    Inhibitor 99.80%
    GDC-0310 is a selective acyl-sulfonamide Nav1.7 inhibitor, with an IC50 of 0.6 nM for hNav1.7.
  • HY-19366
    Nav1.7-IN-2
    Inhibitor 99.81%
    Nav1.7-IN-2 is an inhibitor of voltage-gated sodium channels (Nav), in particular Nav 1.7, with IC50 of 80 nM.
  • HY-107405
    TC-N 1752
    Inhibitor 99.18%
    TC-N 1752 is a potent and orally active inhibitor of Nav1.7, with IC50s of 0.17 μM, 0.3 μM, 0.4 μM, 1.1 μM and 2.2 μM at hNav1.7, hNav1.3, hNav1.4, hNaV1.5 and rNav1.8, respectively.
  • HY-108425
    AMG8379
    Antagonist
    AMG8379 is a potent, orally active and selective sulfonamide antagonist of the voltage-gated sodium channel NaV1.7, with IC50s of 8.5 and 18.6 nM for hNaV1.7 and mNaV1.7, respectively.
  • HY-12883A
    PF-05198007
    Inhibitor 99.77%
    PF-05198007 is a potent, orally active and selective arylsulfonamide Nav1.7 inhibitor.
  • HY-146069
    ABBV-318
    Inhibitor 98.97%
    ABBV-318 is a potent Nav1.7/ Nav1.8 blocker, with IC50s of 2.8 μM and 3.8 μM for hNav1.7 and hNav1.8, respectively.
  • HY-126291
    GNE-616
    Inhibitor
    GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype selective Nav1.7 inhibitor (Ki of 0.79 nM and Kd of 0.38 nM for hNav1.7) for the treatment of chronic pain.
  • HY-108425B
    (Rac)-AMG8379
    Antagonist
    (Rac)-AMG8379 ((Rac)-AMG8380) is a racemate of AMG8379.
  • HY-119934
    NaV1.7 inhibitor-1
    Inhibitor 99.65%
    NaV1.7 inhibitor-1 is an efficacious voltage-gated sodium channel (NaV) 1.7 inhibitor with an IC50 of 0.6 nM for hNaV1.7, exhibits 80-fold selectivity versus hNaV1.5.
  • HY-118048
    NAV 26
    Inhibitor
    NAV 26 (compound 26) is a selective voltage-gated sodium channel Nav1.7 blocker with an IC50 of 0.37 μM.
  • HY-108425A
    AMG8380
    Antagonist
    AMG8380, an orally active and less active enantiomer of AMG8379, can serves as a negative control.
  • HY-141547
    Nav1.7-IN-8
    Inhibitor
    Nav1.7-IN-8 is a potent blockage of NaV1.7 with high selectivity for the inhibition of NaV1.7 over the subtypes hNaV1.1 and hNaV1.5.
  • HY-P1220
    Huwentoxin-IV
    Inhibitor
    Huwentoxin-IV is a potent and selective sodium channel blocker, inhibits neuronal Nav1.7, Nav1.2, Nav1.3 and Nav1.4 with IC50s of 26, 150, 338 and 400 nM, respectively.
  • HY-P1220A
    Huwentoxin-IV TFA
    Inhibitor
    Huwentoxin-IV TFA is a potent and selective sodium channel blocker, inhibits neuronal Nav1.7, Nav1.2, Nav1.3 and Nav1.4 with IC50s of 26, 150, 338 and 400 nM, respectively.